CPT1A and colorectal carcinoma: CPT1A controls fatty acid flux into mitochondria for β-oxidation, the inhibitor etomoxir (ETO) slightly reduced CRC growth alone but significantly extended survival when combined with anti-PD-L1 antibodies (387).